J&J JNJ recently reported new positive data from the phase III MARIPOSA study, which compared the combination of Rybrevant and Lazcluze against AstraZeneca’s AZN Tagrisso in first-line EGFR-mutated ...

AstraZeneca presented new data on TAGRISSO® (osimertinib) at the European Lung Cancer Congress (ELCC) 2025, reinforcing its ...

Feb. 12, 2025 — Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous ... Feb. 6, 2025 ...

Johnson & Johnson has produced the most convincing data to date that its combination of Rybrevant and Lazcluze could replace ...

Stage 4 non-small cell lung cancer (NSCLC) is the most advanced form of the condition and can be challenging to treat. Treatments include chemotherapy, surgery, immunotherapy, and radiotherapy.

Teddi Mellencamp's diagnosis with melanoma in 2022 was just the beginning of a multi-year cancer journey that's ongoing. The 43-year-old, who previously appeared on “The Real Housewives of ...

The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...

Teddi Mellencamp’s doctors discovered more tumors in her body after she underwent emergency brain surgery last month. The "Real Housewives of Beverly Hills" star shared a health update on her ...

"These are all a direct result of my melanoma,” the podcast host wrote in a Thursday, March 6 Instagram post Charna Flam is a writer-reporter at PEOPLE. She has been working at PEOPLE since 2023.

Lung cancer is a disease in which cancerous cells form in the tissues around and inside the lung. There are various types of this disease. Non-small cell lung cancer (NSCLC) is a disease where cancer ...

Objective Despite recent advances in surgical and interventional techniques, knowledge on the management of carcinoid heart disease (CHD) remains limited. In a cohort of patients with liver metastases ...

Oslo — Norwegian Crown Princess Mette-Marit's chronic lung condition has worsened and her public duties may have to be adjusted on short notice in future, the palace said on Thursday. The 51 ...